vobarilizumab (ALX-0061) - Sanofi
Ablynx gets good results for inhaled drug (Reuters) - Sep 18, 2012 - Anticipated P2 RA data in Oct 2012 
Anticipated P2 data • Immunology • Rheumatoid Arthritis
http://in.reuters.com/article/2012/09/18/us-ablynx-rsv-idINBRE88H0CL20120918
 
Sep 18, 2012
 
Ablynx was due to release Phase II results for its rheumatoid arthritis drug, ALX-0061, next month... (IR5)